Medical Equipment

Global Neuromodulation Market 2025–2029: Competitive Insights and Opportunities

November 17, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Neuromodulation Industry By The Forecast Year 2029?

The neuromodulation sector has experienced substantial expansion lately, projected to climb from $6.96 billion in 2024 to $7.62 billion in 2025, achieving a compound annual growth rate of 9.5%; this historical upward trajectory is largely fueled by the increasing incidence of long-term ailments, accumulated clinical validation and ongoing studies, greater patient preference for procedures that do not require invasive methods, support and financing from governmental bodies, the broadening scope of approved applications, and strategic alliances between companies.

Anticipated to expand notably in the forthcoming years, the entire neuromodulation market is projected to achieve a value of $11.57 billion by 2029, demonstrating a consistent compound annual growth rate (CAGR) of 11.0%; this upswing during the projection timeframe is fueled by several factors, such as devices becoming increasingly smaller, a heightened emphasis on addressing neurological conditions affecting the elderly, a broadening scope of uses within psychiatric care, the adoption of methods centered around the patient, and the general widening of healthcare availability worldwide, while key developments shaping this period involve incorporating artificial intelligence (AI), technological leaps forward, the development of neuromodulation methods that do not require invasion, fully automated, feedback-controlled neuromodulation setups, exploration of more conditions for treatment, and the proliferation of wearable, wireless neuromodulation apparatus.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp

What Are The Main Drivers Boosting The Neuromodulation Industry’s Expansion?

Increased incidence of ailments affecting the nervous system is anticipated to fuel the expansion of the neuromodulation sector in the future. These neurological disorders encompass technical issues arising within the brain, the spinal cord, and the peripheral nerves distributed across the body. Neuromodulation provides a mechanism for managing and remedying numerous such conditions and illnesses, including debilitating ones such as Alzheimer’s and Parkinson’s. To illustrate the scale, data from the European Brain Council, an international health coordinating body based in Belgium, indicated in April 2022 that over 600 distinct neurological diseases and approximately 300 psychiatric issues had been identified. Globally, fifty million individuals were afflicted by Alzheimer’s disease alongside other forms of dementia, while epilepsy presented a pervasive condition impacting sixty-five million persons. Specifically in Europe, ten point five million individuals suffered from dementia, a figure projected to climb substantially to eighteen point seven million by the year 2050, underscoring how the escalating occurrence of these nervous system disorders is propelling the neuromodulation market forward.

How Is The Neuromodulation Market Segmented?

The neuromodulationmarket covered in this report is segmented –

1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)

2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial

3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications

4) By End-User: Hospitals, Clinics, Home Healthcare

Subsegments:

1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems

2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

Which Market Trends Are Creating New Opportunities In The Neuromodulation Industry?

A significant and increasingly popular movement within the neuromodulation sector is centered on technological progress, with the leading firms actively concentrating resources on crafting novel technological remedies to solidify their standing. To illustrate this thrust, in January of 2024, GrayMatters Health, an Israeli entity concentrating on digital self-neuromodulation treatments, introduced Prism, a recently cleared self-neuromodulation therapy for Post-Traumatic Stress Disorder (PTSD) by the FDA; this sophisticated instrument integrates an EEG cap and associated software, enabling individuals to gain mastery over their affective reactions via neurofeedback, serving to enhance conventional psychotherapy and drug treatments by equipping sufferers with active symptom management capabilities. Additionally, demonstrating a commitment to innovation, Abbott Laboratories, a US healthcare and medical device corporation, introduced the Eterna spinal cord stimulation (SCS) system in December 2022, which stands out as the most compact rechargeable implantable spinal cord stimulator available, utilizing Abbott’s proprietary low-dose BurstDR stimulation—the sole SCS waveform advancement possessing the preponderance of clinical verification (1A evidence)—which clinical findings indicate surpasses conventional waveform methods in pain alleviation by a margin of 23 percent.

Which Global Market Leaders Are Shaping The Future Of The Neuromodulation Sector?

Major companies operating in the neuromodulation market include Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, Neuropace Inc., LivaNova PLC, Neurosigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, ReShape Lifesciences Inc., Inspire Medical Systems Inc., Bioventus LLC, Saluda Medical Pty Ltd, Otolith Labs Inc., Machine Medicine Inc., Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuronoff ApS, Neuros Medical Inc., Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., Magic Leap Inc., Omron Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Neuromodulation Market?

North America was the largest region in the neuromodulation market in 2024. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Neuromodulation Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10142&type=smp

Browse Through More Reports Similar to the Global Neuromodulation Market 2025, By The Business Research Company

Neurology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Neurodegenerative Disorder Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Neurophysiology Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795